NECLIFENSENectar Lifesciences Limited· PharmaceuticalsLowNeutral
Announced Thu, 9 Apr · 17:38 IST

Sanjiv Goyal self and Karta of Sanjiv (HUF), Raman Goyal has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.

Pledge ReleasedOwnership Changes View source PDF

NECLIFE · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
+11.3%1-day move
₹10.74
prior close
₹10.85
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+0.8+1.2+4.1+8.3+11.3+14.9+15.5+19.9+15.0+15.0+12.9+27.0+7.1+4.2
Up moveDown movePending
AI summary

Promoters Sanjiv Goyal, Raman Goyal, and Sanjiv (HUF) have submitted a declaration to the stock exchanges confirming that no encumbrance (pledge) on shares of Nectar Lifesciences Limited was created directly or indirectly during the Financial Year ending March 31, 2026. This is a routine regulatory compliance filing under SEBI takeovers regulations, where promoters periodically declare their pledge status. The declaration covers the entire promoter group including Sanjiv Goyal and Sanjiv (HUF) as Promoters and Raman Goyal as part of the Promoter Group.

Likely market impact

A 'no encumbrance' declaration is positive for shareholders as it indicates promoters have not leveraged their shareholding through loans, reducing risk of forced selling. This is neutral from a trading perspective but reflects a healthy promoter balance sheet.